Search research articles
Contact Us
Filters
Showing results (111-120 of 154) with videos related to
Page
of 16
Sort By:
Gastroenterology
|
May 27, 2018
Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis
Marcia Cruz-Correa, Linda M Hylind, Jessica Hernandez Marrero, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 18, 2026
Simvastatin Treatment in Patients with Liver Cirrhosis: a Phase II Randomized Placebo Controlled Trial Shows Reduction in IL-6 Levels
Shehnaz K Hussain, Walid S Ayoub, Marcia Cruz-Correa, et al.
Epigenomics
|
December 22, 2020
Novel methylated DNA markers accurately discriminate Lynch syndrome associated colorectal neoplasia
Veroushka Ballester, William R Taylor, Seth W Slettedahl, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 27, 2025
A phase I dose escalation study of Polyphenon E in liver cirrhosis: Evaluation of safety and effect on liver γ-OHPdG levels
Aiwu Ruth He, Coleman I Smith, Marcia Cruz-Correa, et al.
Advances in Therapy
|
November 18, 2025
Tislelizumab + Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-up
Marcia Cruz-Correa, Do-Youn Oh, Ken Kato, et al.
Cancer Research
|
March 15, 2008
Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition
Duyen T Dang, Sang Y Chun, Kyunghee Burkitt, et al.
Science Progress
|
July 25, 2024
Comparison of bone mineral density between female amateur triathletes and nonathletes: A cross-sectional study
Guilherme Cruz Correa Netto Soares, José Geraldo Gomes Barbosa Junior, Aldo Seffrin, et al.
Current Medical Research and Opinion
|
June 18, 2025
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment of advanced gastric or gastroesophageal junction adenocarcinoma: patient-reported outcomes in the RATIONALE-305 study
Marcia Cruz-Correa, Rui-Hua Xu, Markus Moehler, et al.
Gastroenterology
|
February 22, 2017
Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome
Joseph C Anderson, John A Baron, Dennis J Ahnen, et al.
Journal of Global Oncology
|
February 26, 2019
Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline
Gilberto Lopes, Mariana C Stern, Sarah Temin, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 154) with videos related to
Sort By:
Page
of 16
Gastroenterology
|
May 27, 2018
Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis
Marcia Cruz-Correa, Linda M Hylind, Jessica Hernandez Marrero, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 18, 2026
Simvastatin Treatment in Patients with Liver Cirrhosis: a Phase II Randomized Placebo Controlled Trial Shows Reduction in IL-6 Levels
Shehnaz K Hussain, Walid S Ayoub, Marcia Cruz-Correa, et al.
Epigenomics
|
December 22, 2020
Novel methylated DNA markers accurately discriminate Lynch syndrome associated colorectal neoplasia
Veroushka Ballester, William R Taylor, Seth W Slettedahl, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 27, 2025
A phase I dose escalation study of Polyphenon E in liver cirrhosis: Evaluation of safety and effect on liver γ-OHPdG levels
Aiwu Ruth He, Coleman I Smith, Marcia Cruz-Correa, et al.
Advances in Therapy
|
November 18, 2025
Tislelizumab + Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-up
Marcia Cruz-Correa, Do-Youn Oh, Ken Kato, et al.
Cancer Research
|
March 15, 2008
Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition
Duyen T Dang, Sang Y Chun, Kyunghee Burkitt, et al.
Science Progress
|
July 25, 2024
Comparison of bone mineral density between female amateur triathletes and nonathletes: A cross-sectional study
Guilherme Cruz Correa Netto Soares, José Geraldo Gomes Barbosa Junior, Aldo Seffrin, et al.
Current Medical Research and Opinion
|
June 18, 2025
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment of advanced gastric or gastroesophageal junction adenocarcinoma: patient-reported outcomes in the RATIONALE-305 study
Marcia Cruz-Correa, Rui-Hua Xu, Markus Moehler, et al.
Gastroenterology
|
February 22, 2017
Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome
Joseph C Anderson, John A Baron, Dennis J Ahnen, et al.
Journal of Global Oncology
|
February 26, 2019
Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline
Gilberto Lopes, Mariana C Stern, Sarah Temin, et al.
Page
of 16